Deng Shuo, Leong Hin Chong, Datta Arpita, Gopal Vennila, Kumar Alan Prem, Yap Celestial T
Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117593, Singapore.
NUS Centre for Cancer Research (N2CR), Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117597, Singapore.
Cancers (Basel). 2022 Mar 24;14(7):1652. doi: 10.3390/cancers14071652.
The PI3K/AKT signaling pathway plays essential roles in multiple cellular processes, which include cell growth, survival, metabolism, and motility. In response to internal and external stimuli, the PI3K/AKT signaling pathway co-opts other signaling pathways, cellular components, and cytoskeletal proteins to reshape individual cells. The cytoskeletal network comprises three main components, which are namely the microfilaments, microtubules, and intermediate filaments. Collectively, they are essential for many fundamental structures and cellular processes. In cancer, aberrant activation of the PI3K/AKT signaling cascade and alteration of cytoskeletal structures have been observed to be highly prevalent, and eventually contribute to many cancer hallmarks. Due to their critical roles in tumor progression, pharmacological agents targeting PI3K/AKT, along with cytoskeletal components, have been developed for better intervention strategies against cancer. In our review, we first discuss existing evidence in-depth and then build on recent advances to propose new directions for therapeutic intervention.
PI3K/AKT信号通路在多种细胞过程中发挥着重要作用,这些过程包括细胞生长、存活、代谢和运动。响应内部和外部刺激时,PI3K/AKT信号通路会借助其他信号通路、细胞成分和细胞骨架蛋白来重塑单个细胞。细胞骨架网络由三个主要成分组成,即微丝、微管和中间丝。它们共同对许多基本结构和细胞过程至关重要。在癌症中,已观察到PI3K/AKT信号级联的异常激活和细胞骨架结构的改变非常普遍,并最终促成了许多癌症特征。由于它们在肿瘤进展中的关键作用,已开发出针对PI3K/AKT以及细胞骨架成分的药物制剂,以制定更好的癌症干预策略。在我们的综述中,我们首先深入讨论现有证据,然后基于最近的进展提出治疗干预的新方向。